LFD-200

· Lifordi Immunotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LFD-200, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis [Phase 1]